Showing results (11-20 of 66) with videos related to

Sort By:
Pageof 7
Pharmaceuticals (Basel, Switzerland)|July 27, 2024
Cancer Cell Secreted Legumain Promotes Gastric Cancer Resistance to Anti-PD-1 Immunotherapy by Enhancing Macrophage M2 PolarizationXu Pei, Shi-Long Zhang, Bai-Quan Qiu, et al.
Psychological Medicine|April 1, 2026
Triglyceride-glucose index, genetic predisposition, and incident depression: a prospective cohort study from the UK BiobankWei Hu, Tian-Shu Liu, Zhen-Zhen Shen, et al.
Spectrochimica Acta. Part A, Molecular and Biomolecular Spectroscopy|February 19, 2008
The synthesis, crystal structure and spectroscopic properties of luminescent Zn(II) complexPing Cai, Jing-Ran Hou, Tian-Shu Liu, et al.
Nanomaterials (Basel, Switzerland)|August 15, 2018
Effects of Carbon Source on TiC Particles' Distribution, Tensile, and Abrasive Wear Properties of In Situ TiC/Al-Cu Nanocomposites Prepared in the Al-Ti-C SystemYu-Yang Gao, Feng Qiu, Tian-Shu Liu, et al.
Andrologia|April 23, 2019
Mesenchymal stem cell-secreted factors delayed spermatogenesis injuries induced by busulfan involving intercellular adhesion molecule regulationYi-Ting Cai, Cheng-Liang Xiong, Shi-Liang Shen, et al.
Andrologia|June 18, 2021
Secretions released from mesenchymal stem cells improve spermatogenesis restoration of cytotoxic treatment with busulfan in azoospermia miceYi-Ting Cai, Cheng-Liang Xiong, Tian-Shu Liu, et al.
The Prostate|February 28, 2020
The underlying mechanism of metabolic syndrome on benign prostatic hyperplasia and prostate volumeBo-Wen Xia, Si-Cong Zhao, Zong-Ping Chen, et al.
Scientific Reports|July 9, 2021
Relationship between serum total testosterone and prostate volume in aging menBo-Wen Xia, Si-Cong Zhao, Zong-Ping Chen, et al.
BMC Urology|November 23, 2019
The association of pathogenic factors of metabolic syndrome on serum prostate-specific antigen levels: a pilot studyBo-Wen Xia, Si-Cong Zhao, Zong-Ping Chen, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|December 10, 2013
[Efficacy and safety of bevacizumab (BEV) plus chemotherapeutic agents in the treatment of metastatic colorectal cancer, mCRC]Xi Guo, Tian-shu Liu, Yi-yi Yu, et al.
Pageof 7